These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34830871)

  • 1. Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists.
    Xing DT; Khor R; Gan H; Wada M; Ermongkonchai T; Ng SP
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma.
    Ngamphaiboon N; Chairoungdua A; Dajsakdipon T; Jiarpinitnun C
    Oral Oncol; 2023 Oct; 145():106520. PubMed ID: 37467684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
    Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
    Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Taberna M; Oliva M; Mesía R
    Front Oncol; 2019; 9():383. PubMed ID: 31165040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma.
    Nindra U; Hurwitz J; Forstner D; Chin V; Gallagher R; Liu J
    Cancer Med; 2023 May; 12(10):11234-11247. PubMed ID: 36934434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining radiotherapy and immunotherapy in definitive treatment of head and neck squamous cell carcinoma: review of current clinical trials.
    Plavc G; Strojan P
    Radiol Oncol; 2020 Oct; 54(4):377-393. PubMed ID: 33064670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
    Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
    Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
    Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
    Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Immunotherapy in Head and Neck Cancer.
    Ling DC; Bakkenist CJ; Ferris RL; Clump DA
    Semin Radiat Oncol; 2018 Jan; 28(1):12-16. PubMed ID: 29173750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy in head and neck squamous cell carcinoma : Abscopal effects in combination with radiotherapy, extraordinary responses in combination with chemotherapy, and pseudoprogression].
    Brix N; Dunn L; Seiwert T; Belka C; Lauber K
    Internist (Berl); 2020 Jul; 61(7):682-689. PubMed ID: 32462252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review.
    Sanwick AM; Chaple IF
    Front Oncol; 2024; 14():1445191. PubMed ID: 39239273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of radiation therapy-immunotherapy for head and neck cancers: Promises kept?
    Huguet F; Durand B; Atallah S; Prébet C; Richard S; Baujat B
    Cancer Radiother; 2021 Dec; 25(8):811-815. PubMed ID: 34711485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The abscopal effect in head-and-neck squamous cell carcinoma treated with radiotherapy and nivolumab: a case report and literature review.
    Forner D; Horwich P; Trites JR; Hollenhorst H; Bullock M; Lamond NWD
    Curr Oncol; 2020 Dec; 27(6):330-335. PubMed ID: 33380865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer.
    Tathineni P; Joshi N; Jelinek MJ
    Curr Treat Options Oncol; 2023 Jun; 24(6):680-692. PubMed ID: 37067660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives.
    Daste A; Larroquette M; Gibson N; Lasserre M; Domblides C
    Immunotherapy; 2024 Feb; 16(3):187-197. PubMed ID: 38126161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of head and neck squamous cell carcinoma.
    Pan Q; Gorin MA; Teknos TN
    Expert Opin Pharmacother; 2009 Oct; 10(14):2291-302. PubMed ID: 19663637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
    Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
    Front Immunol; 2021; 12():652054. PubMed ID: 34305889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
    Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak AR; Chen EX; Jang R; O'Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR
    Invest New Drugs; 2016 Oct; 34(5):575-83. PubMed ID: 27289242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis.
    Wang H; Zheng Z; Zhang Y; Bian C; Bao J; Xin Y; Jiang X
    Front Pharmacol; 2023; 14():1269863. PubMed ID: 37795033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.